Gut 2007;56:1325
LETTER
Remission and relapse of Crohns disease following autologous haematopoietic stem cell transplantation for non-Hodgkins lymphoma
Department of Gastroenterology, Kings College Hospital, London SE5 9RS, UK; guy.chung-faye@kingsch.nhs.uk
Keywords: Crohns disease; non-Hodgkins lymphoma; stem cell transplantation
| The first 150 words of the full text of this article appear below. |
Autologous haematopoietic stem cell transplantation (HSCT) for Crohns disease has been described by Oyama and co-workers as producing remission in 11 of 12 patients with refractory Crohns disease after a median follow up of 18.5 months.1 They postulated that autologous HSCT was useful for refractory Crohns disease. We report the case of a 32 year old woman with biopsy proven Crohns disease diagnosed when she was 16 years old. Her mother also suffered from Crohns disease. She developed a KI1 positive anaplastic non-Hodgkins lymphoma (NHL) three years later, treated successfully with ablative CHOP chemotherapy and autologous HSCT, inducing remission for the past 12 years (and she remains in remission on no treatment). As a consequence of her autologous HSCT she also went into long term remission from her Crohns disease, but relapsed after eight years. She was a smoker, but was on no maintenance treatment for Crohns disease in this
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
